Aeglea raises $50M in IPO

Aeglea Biotherapeutics Inc. (NASDAQ:AGLE) shed $0.23 to $9.77 in its first day of

Read the full 134 word article

User Sign In

Article Purchase

This article may not be distributed to non-subscribers

PURCHASE THIS ARTICLE FOR LIMITED ONE-TIME DISTRIBUTION AND WEBSITE POSTING $995.00 USD

PURCHASE